Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| 1 |
AbbVie
ABBV
|
+$1.41B |
| 2 |
Eli Lilly
LLY
|
+$945M |
| 3 |
Exxon Mobil
XOM
|
+$890M |
| 4 |
RTX Corp
RTX
|
+$675M |
| 5 |
Verizon
VZ
|
+$660M |
Top Sells
| 1 |
JPMorgan Chase
JPM
|
+$1.81B |
| 2 |
Deutsche Bank
DB
|
+$1.49B |
| 3 |
Amgen
AMGN
|
+$1.06B |
| 4 |
Charles Schwab
SCHW
|
+$1.02B |
| 5 |
Broadcom
AVGO
|
+$965M |
Sector Composition
| 1 | Technology | 19.65% |
| 2 | Healthcare | 16.3% |
| 3 | Consumer Discretionary | 11.31% |
| 4 | Industrials | 10.89% |
| 5 | Financials | 8.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Progressive
PGR
$146B
| $233M | 0.07% |
2,006,077
-292
| -0% | -$34K |
|
|
OSH
202
DELISTED
Oak Street Health, Inc.
OSH
| $228M | 0.07% |
13,873,788
+2,021,708
| +17% | +$33.2M |
|
203
McCormick & Company Non-Voting
MKC
$18.5B
| $226M | 0.07% |
2,714,592
-675
| -0% | -$56.2K |
|
204
Intuit
INTU
$180B
| $217M | 0.07% |
562,440
+24,204
| +4% | +$9.33M |
|
|
AVGOP
205
DELISTED
Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A
AVGOP
| $210M | 0.07% |
139,393
| – | – |
|
206
Integra LifeSciences
IART
$1.17B
| $209M | 0.07% |
3,869,770
-2,948,154
| -43% | -$159M |
|
207
Cencora
COR
$58.7B
| $208M | 0.06% |
1,468,896
-1,954,881
| -57% | -$277M |
|
208
Thor Industries
THO
$5.55B
| $208M | 0.06% |
2,778,105
-1,504,733
| -35% | -$112M |
|
209
Yum! Brands
YUM
$41.5B
| $207M | 0.06% |
1,824,800
-144
| -0% | -$16.3K |
|
210
Franklin Resources
BEN
$12.8B
| $204M | 0.06% |
8,767,561
+73,935
| +0.9% | +$1.72M |
|
211
Futu Holdings
FUTU
$25.9B
| $204M | 0.06% |
3,912,249
+952,014
| +32% | +$49.7M |
|
212
DT Midstream
DTM
$10.9B
| $199M | 0.06% |
4,067,323
+2,526,821
| +164% | +$124M |
|
213
Lufax Holding
LU
$2.61B
| $195M | 0.06% |
8,128,551
+34,040
| +0.4% | +$817K |
|
214
Five Below
FIVE
$7.71B
| $195M | 0.06% |
1,716,346
+684
| +0% | +$77.6K |
|
215
Icon
ICLR
$13.6B
| $193M | 0.06% |
892,533
+166,136
| +23% | +$36M |
|
216
Omnicom Group
OMC
$15B
| $193M | 0.06% |
3,036,585
-2,952,410
| -49% | -$188M |
|
217
Telus
TU
$24.3B
| $193M | 0.06% |
8,657,334
-11,475,450
| -57% | -$256M |
|
218
Enbridge
ENB
$107B
| $191M | 0.06% |
4,534,146
+585
| +0% | +$24.7K |
|
219
Constellation Energy
CEG
$101B
| $191M | 0.06% |
3,335,655
+111,870
| +3% | +$6.41M |
|
220
Confluent
CFLT
$6.63B
| $190M | 0.06% |
8,189,420
+6,256,824
| +324% | +$145M |
|
221
Dollar Tree
DLTR
$19.9B
| $190M | 0.06% |
1,217,914
+4,608
| +0.4% | +$718K |
|
222
Agilon Health
AGL
$443M
| $189M | 0.06% |
8,646,210
-1,221,665
| -12% | -$26.7M |
|
223
Tradeweb Markets
TW
$25.2B
| $188M | 0.06% |
2,754,049
-4,371,530
| -61% | -$298M |
|
224
Merck
MRK
$207B
| $186M | 0.06% |
2,036,860
-116
| -0% | -$10.6K |
|
225
East-West Bancorp
EWBC
$15.1B
| $186M | 0.06% |
2,863,463
-1,375,426
| -32% | -$89.1M |
|